Nykode Therapeutics ASA (NYKD) — Financial Flexibility Index
Nykode Therapeutics ASA (NYKD) has a Financial Flexibility Index of -9.25x as of September 2025. Free cash flow of Nkr-59.62 Million (operating CF Nkr-59.64 Million minus capex Nkr18.29K) represents -9% of total liabilities (Nkr6.45 Million). Check NYKD strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nykode Therapeutics ASA Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Nykode Therapeutics ASA across 9 annual periods. See Nykode Therapeutics ASA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Nykode Therapeutics ASA (2016–2024)
Year-by-year free cash flow to debt coverage for Nykode Therapeutics ASA. For the full company profile including market capitalisation, see NYKD company net worth.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.96x | Nkr-51.15 Million | Nkr-51.22 Million | Nkr17.27 Million | ▼ -15.5% |
| 2023 | -2.57x | Nkr-94.72 Million | Nkr-96.62 Million | Nkr36.93 Million | ▼ -817.7% |
| 2022 | -0.28x | Nkr-18.02 Million | Nkr-20.69 Million | Nkr64.46 Million | ▼ -1086.5% |
| 2021 | 0.03x | Nkr2.03 Million | Nkr1.16 Million | Nkr71.50 Million | ▼ -99.2% |
| 2020 | 3.52x | Nkr180.37 Million | Nkr180.27 Million | Nkr51.18 Million | ▲ +294.8% |
| 2019 | -1.81x | Nkr-91.41 Million | Nkr-92.08 Million | Nkr50.52 Million | ▲ +61.7% |
| 2018 | -4.73x | Nkr-62.70 Million | Nkr-62.78 Million | Nkr13.27 Million | ▲ +17.6% |
| 2017 | -5.73x | Nkr-62.70 Million | Nkr-62.78 Million | Nkr10.94 Million | ▼ -527.0% |
| 2016 | -0.91x | Nkr-1.59 Million | Nkr-1.60 Million | Nkr1.74 Million | — |